TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Nordic Biolabs AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
112,906
|
108,748
|
114,954 |
Financial expenses |
182
|
39
|
2 |
Earnings before taxes |
-2,910
|
-1,372
|
5,889 |
EBITDA |
-1,470
|
29
|
7,302 |
Total assets |
39,240
|
33,378
|
36,405 |
Current assets |
36,633
|
29,820
|
32,611 |
Current liabilities |
25,989
|
22,020
|
20,352 |
Equity capital |
13,184
|
10,683
|
15,035 |
- share capital |
2,431
|
2,270
|
2,341 |
Employees (average) |
30
|
28
|
25 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
33.6%
|
32.0%
|
41.3% |
Turnover per employee |
3,764
|
3,884
|
4,598 |
Profit as a percentage of turnover |
-2.6%
|
-1.3%
|
5.1% |
Return on assets (ROA) |
-7.0%
|
-4.0%
|
16.2% |
Current ratio |
141.0%
|
135.4%
|
160.2% |
Return on equity (ROE) |
-22.1%
|
-12.8%
|
39.2% |
Change turnover |
-3,558
|
-2,752
|
-16,001 |
Change turnover % |
-3%
|
-2%
|
-12% |
Chg. No. of employees |
2
|
3
|
2 |
Chg. No. of employees % |
7%
|
12%
|
9% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.